
Zoetis Inc.: shareholders and insiders
Price
$80.79
November 19, 2026Market cap $34.1B
What Ploutos Investor adds for Zoetis
Part of Ploutos Investor, €9.99 a month
- The full history: 15 fiscal years, from 2011
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 20, 2025 to Nov 3, 2026, from their own Form 4 filings.
Bought on the market
$886.4K
3 people
Sold on the market
$2.5M
1 person
From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan100%
- The rest0%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 20, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $886.4K by 3 people·sold $2.5M by 1 person
- 2025: no buys, no sales
- 2026: bought $886.4K by 3 people, sold $2.5M by 1 person
- Sep 30, 2026Julie FullerExecutive Vice PresidentKind
- Sep 30, 2026Julie FullerExecutive Vice PresidentKind
- Aug 7, 2026Frank A DamelioDirectorKind
- Jun 10, 2026Michael B MccallisterDirectorKind
- May 21, 2026Mark StetterDirectorKind
- May 13, 2026Paul BisaroKind
- May 13, 2026Frank A DamelioKind
- May 11, 2026Michael B MccallisterKind
- Feb 17, 2026Kristin C PeckChief Executive OfficerKind10b5-1
- Feb 17, 2026Kristin C PeckChief Executive OfficerKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Julie FullerExecutive Vice President | 799 | – | – | Form 4 | |
| Sep 30, 2026 | Julie FullerExecutive Vice President | 274 | $69.83 | $19.1K | Form 4 | |
| Aug 7, 2026 | Frank A DamelioDirector | 6,650 | – | – | Form 4 | |
| Jun 10, 2026 | Michael B MccallisterDirector | 1,209 | – | – | Form 4 | |
| May 21, 2026 | Mark StetterDirector | 1,572 | – | – | Form 4 | |
| May 13, 2026 | Paul Bisaro | 2,000 | $75.88 | $151.8K | Form 4 | |
| May 13, 2026 | Frank A Damelio | 6,650 | $75.39 | $501.3K | Form 4 | |
| May 11, 2026 | Michael B Mccallister | 3,000 | $77.76 | $233.3K | Form 4 | |
| Feb 17, 2026 | Kristin C PeckChief Executive Officer | 10b5-1 | 9,200 | $126.46 | $1.2M | Form 4 |
| Feb 17, 2026 | Kristin C PeckChief Executive Officer | 10b5-1 | 10.8K | $127.55 | $1.4M | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by ZTS's officers and directors from 2013 up to November 19, 2025, 13 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 8 more, back to 2013
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Class A StockShare of class9.00%
- Vanguard Capital ManagementShare of class7.17%
- Vanguard Portfolio ManagementShare of class5.70%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc.Class A Stock | 9.00% | 37.66M | Jul 30, 2026 | 13G/A | |
| Vanguard Capital Management | 7.17% | 30.28M | Apr 30, 2026 | 13G | |
| Vanguard Portfolio Management | 5.70% | 24.07M | Apr 29, 2026 | 13G |
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 27, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter+18%
- Citadel Advisors (Griffin)In the quarter+536%
- Millennium Mgmt (Englander)In the quarter+9.9%
- Bridgewater (Dalio)In the quarter+164%
- AQR CapitalIn the quarter+76%
- D.E. ShawIn the quarter+615%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 1.66M | +18% | $116M | 0.16% |
| Citadel Advisors (Griffin) | 3.19M | +536% | $229M | 0.13% |
| Millennium Mgmt (Englander) | 1.81M | +9.9% | $130M | 0.09% |
| Bridgewater (Dalio) | 134.2K | +164% | $9.6M | 0.04% |
| AQR Capital | 1.07M | +76% | $77M | 0.03% |
| D.E. Shaw | 537.5K | +615% | $39M | 0.02% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 4.15% of its shares outstanding were held short, -4.9% since the report before.
- Shares held short
- 17.52M
- 4.15%
- Since the report before18.42M on Sep 30, 2026
- -4.9%
- 4.1
- 4.32M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 49%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 3.10M
- Nov 15, 2023: Shares held short 3.02M
- Nov 30, 2023: Shares held short 3.34M
- Dec 15, 2023: Shares held short 3.68M
- Dec 29, 2023: Shares held short 3.01M
- Jan 12, 2024: Shares held short 2.75M
- Jan 31, 2024: Shares held short 2.96M
- Feb 15, 2024: Shares held short 3.41M
- Feb 29, 2024: Shares held short 3.77M
- Mar 15, 2024: Shares held short 3.57M
- Mar 28, 2024: Shares held short 3.65M
- Apr 15, 2024: Shares held short 3.18M
- Apr 30, 2024: Shares held short 5.17M
- May 15, 2024: Shares held short 6.03M
- May 31, 2024: Shares held short 5.80M
- Jun 14, 2024: Shares held short 6.88M
- Jun 28, 2024: Shares held short 6.25M
- Jul 15, 2024: Shares held short 5.30M
- Jul 31, 2024: Shares held short 4.65M
- Aug 15, 2024: Shares held short 4.06M
- Aug 30, 2024: Shares held short 5.09M
- Sep 13, 2024: Shares held short 5.04M
- Sep 30, 2024: Shares held short 5.10M
- Oct 15, 2024: Shares held short 4.38M
- Oct 31, 2024: Shares held short 4.32M
- Nov 15, 2024: Shares held short 4.69M
- Nov 29, 2024: Shares held short 5.48M
- Dec 13, 2024: Shares held short 6.26M
- Dec 31, 2024: Shares held short 6.99M
- Jan 15, 2025: Shares held short 7.12M
- Jan 31, 2025: Shares held short 8.58M
- Feb 14, 2025: Shares held short 8.23M
- Feb 28, 2025: Shares held short 6.51M
- Mar 14, 2025: Shares held short 7.12M
- Mar 31, 2025: Shares held short 6.90M
- Apr 15, 2025: Shares held short 7.74M
- Apr 30, 2025: Shares held short 9.33M
- May 15, 2025: Shares held short 10.21M
- May 30, 2025: Shares held short 10.54M
- Jun 13, 2025: Shares held short 8.69M
- Jun 30, 2025: Shares held short 9.15M
- Jul 15, 2025: Shares held short 7.85M
- Jul 31, 2025: Shares held short 6.88M
- Aug 15, 2025: Shares held short 6.60M
- Aug 29, 2025: Shares held short 7.76M
- Sep 15, 2025: Shares held short 9.19M
- Sep 30, 2025: Shares held short 7.99M
- Oct 15, 2025: Shares held short 8.73M
- Oct 31, 2025: Shares held short 11.07M
- Nov 14, 2025: Shares held short 8.25M
- Nov 28, 2025: Shares held short 9.18M
- Dec 15, 2025: Shares held short 10.88M
- Dec 31, 2025: Shares held short 13.74M
- Jan 15, 2026: Shares held short 15.56M
- Jan 30, 2026: Shares held short 14.15M
- Feb 13, 2026: Shares held short 16.33M
- Feb 27, 2026: Shares held short 17.30M
- Mar 13, 2026: Shares held short 15.70M
- Mar 31, 2026: Shares held short 15.12M
- Apr 15, 2026: Shares held short 13.50M
- Apr 30, 2026: Shares held short 14.80M
- May 15, 2026: Shares held short 13.37M
- May 29, 2026: Shares held short 13.46M
- Jun 15, 2026: Shares held short 16.11M
- Jun 30, 2026: Shares held short 15.92M
- Jul 15, 2026: Shares held short 18.79M
- Jul 31, 2026: Shares held short 21.35M
- Aug 14, 2026: Shares held short 16.78M
- Aug 31, 2026: Shares held short 19.43M
- Sep 15, 2026: Shares held short 17.39M
- Sep 30, 2026: Shares held short 18.42M
- Oct 15, 2026: Shares held short 17.52M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading38.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 38.5% of the shares in the reported trades were short sales, against 40.4% in the 14 before.
- Last 14 sessionsNov 2, 2026 – Nov 19, 2026
- 38.5%
- The 14 beforeOct 13, 2026 – Oct 30, 2026
- 40.4%
- Change
- -1.9 pts
- Short sales a dayon average, of 2.07M shares
- 796.0K
- More than atof 3,666 US-listed companies, same days
- 16%
- Median of alleight in ten from 34.5% to 63.8%
- 50.4%
- Short sales
- Oct 13, 2026: Short sales 40.9%
- Oct 14, 2026: Short sales 50.8%
- Oct 15, 2026: Short sales 36.1%
- Oct 16, 2026: Short sales 36.3%
- Oct 19, 2026: Short sales 40.6%
- Oct 20, 2026: Short sales 46.4%
- Oct 21, 2026: Short sales 50.1%
- Oct 22, 2026: Short sales 24.4%
- Oct 23, 2026: Short sales 47.1%
- Oct 26, 2026: Short sales 38.6%
- Oct 27, 2026: Short sales 44.6%
- Oct 28, 2026: Short sales 49.3%
- Oct 29, 2026: Short sales 37.1%
- Oct 30, 2026: Short sales 40%
- Nov 2, 2026: Short sales 49.8%
- Nov 3, 2026: Short sales 48.1%
- Nov 4, 2026: Short sales 32.1%
- Nov 5, 2026: Short sales 41.6%
- Nov 6, 2026: Short sales 34.6%
- Nov 9, 2026: Short sales 30%
- Nov 10, 2026: Short sales 26.4%
- Nov 11, 2026: Short sales 21.9%
- Nov 12, 2026: Short sales 58.4%
- Nov 13, 2026: Short sales 56.6%
- Nov 16, 2026: Short sales 42.8%
- Nov 17, 2026: Short sales 43.2%
- Nov 18, 2026: Short sales 38%
- Nov 19, 2026: Short sales 36.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Kristin C PeckChief Executive OfficerDirectly112.1K
- Michael B MccallisterDirectorDirectly7,369
- Paul BisaroDirectorDirectly27.9K
- Frank A DamelioDirectorDirectly21.5K
- Roxanne LaganoExecutive Vice PresidentDirectly15.1K
- Willie M ReedDirectorDirectly11.2K
- Robert J PolzerExecutive Vice PresidentDirectly3,249
- Julie FullerExecutive Vice PresidentDirectly1,588
- Mark StetterDirectorDirectly1,572
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Kristin C PeckChief Executive Officer | 112.1K | – | Feb 17, 2026 | Form 4 |
| Michael B MccallisterDirector | 7,369 | 24.5K | Jun 10, 2026 | Form 4 |
| Paul BisaroDirector | 27.9K | – | May 13, 2026 | Form 4 |
| Frank A DamelioDirector | 21.5K | – | Aug 7, 2026 | Form 4 |
| Roxanne LaganoExecutive Vice President | 15.1K | – | Jun 3, 2025 | Form 4 |
| Willie M ReedDirector | 11.2K | – | Mar 11, 2025 | Form 4 |
| Robert J PolzerExecutive Vice President | 3,249 | – | Nov 25, 2024 | Form 4 |
| Julie FullerExecutive Vice President | 1,588 | – | Sep 30, 2026 | Form 4 |
| Mark StetterDirector | 1,572 | – | May 21, 2026 | Form 4 |
A lower bound: it counts only the 9 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
10b5-1 trading plans
Since 2023 every 10-Q and 10-K says which insiders adopted or ended a trading plan (Rule 10b5-1) in the quarter: when, for how many shares, until when. A plan explains the sales that follow months before they show up on Form 4.
- Kristin PeckChief Executive OfficerWhat happenedAdoptedSep 12, 2025Shares–
- Roxanne LaganoExecutive Vice President, General Counsel and Corporate SecretaryWhat happenedAdoptedSep 13, 2024Shares–
- Kristin PeckChief Executive OfficerWhat happenedAdoptedSep 12, 2024Shares52.0K
- Kristin PeckChief Executive OfficerWhat happenedEndedMay 8, 2024Shares52.0K
- Kristin PeckChief Executive OfficerWhat happenedAdoptedFeb 20, 2024Shares52.0K
- Heidi ChenExecutive Vice PresidenWhat happenedAdoptedDec 15, 2023Shares8,310
- Heidi ChenExecutive Vice President, General Counsel and Corporate Secretary; Business Lead of Human Health DiagnosticsWhat happenedAdoptedJun 15, 2023Shares9,905
- Roxanne LaganoExecutive Vice President, Chief Human Resources Officer and Global OperationsWhat happenedAdoptedJun 1, 2023Shares10.8K
| Person | What happened | Until | Shares | Filing |
|---|---|---|---|---|
| Kristin PeckChief Executive Officer | AdoptedSep 12, 2025 | – | – | 10-Q |
| Roxanne LaganoExecutive Vice President, General Counsel and Corporate Secretary | AdoptedSep 13, 2024 | – | – | 10-Q |
| Kristin PeckChief Executive Officer | AdoptedSep 12, 2024 | Dec 31, 2025 | 52.0K | 10-Q |
| Kristin PeckChief Executive Officer | EndedMay 8, 2024 | Apr 30, 2025 | 52.0K | 10-Q |
| Kristin PeckChief Executive Officer | AdoptedFeb 20, 2024 | – | 52.0K | 10-Q |
| Heidi ChenExecutive Vice Presiden | AdoptedDec 15, 2023 | – | 8,310 | 10-K |
| Heidi ChenExecutive Vice President, General Counsel and Corporate Secretary; Business Lead of Human Health Diagnostics | AdoptedJun 15, 2023 | – | 9,905 | 10-Q |
| Roxanne LaganoExecutive Vice President, Chief Human Resources Officer and Global Operations | AdoptedJun 1, 2023 | – | 10.8K | 10-Q |
As the company states them in Item 9B of the 10-K and Part II, Item 5 of the 10-Q, with structured data. A plan allows sales on preset dates and prices. It does not say whether all of them will be executed.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$19M
Actually paid: $2.8M
$4.0M
Actually paid: $1.5M
$80
Peers: $188
Revenue
$9.5B
From the proxy statement (DEF 14A) of Apr 8, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
- Jun 30, 202610-QAmount$550M
- Mar 31, 202610-QAmount$619M
- Dec 31, 202510-KAmount$2.1B
- Sep 30, 202510-QAmount$377M
- Jun 30, 202510-QAmount$337M
- Mar 31, 202510-QAmount$462M
- Dec 31, 202410-KAmount$553M
- Sep 30, 202410-QAmount$426M
| Quarter | Shares | Average price | Amount | Left in the program | Filing |
|---|---|---|---|---|---|
| Jun 30, 202610-Q | 6.21M | $88.59 | $550M | $1.3B | 10-Q |
| Mar 31, 202610-Q | 4.95M | $125.07 | $619M | $1.8B | 10-Q |
| Dec 31, 202510-K | 16.57M | $124.31 | $2.1B | $2.4B | 10-K |
| Sep 30, 202510-Q | 2.49M | $151.42 | $377M | $4.5B | 10-Q |
| Jun 30, 202510-Q | 2.14M | $157.48 | $337M | $4.9B | 10-Q |
| Mar 31, 202510-Q | 2.80M | $165.05 | $462M | $5.2B | 10-Q |
| Dec 31, 202410-K | 3.12M | $177.26 | $553M | $5.6B | 10-K |
| Sep 30, 202410-Q | 2.32M | $183.49 | $426M | $6.2B | 10-Q |
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 2 filing(s) not shown, as the table was not read or did not agree with the cash.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026May 22, 2026For85.6%
- 2025May 22, 2025For90.5%
- 2024May 23, 2024For90.9%
- 2023May 19, 2023For93.2%
- 2022May 20, 2022For93.4%
- 2021May 21, 2021For92.1%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026May 22, 2026 | 85.6% | 306M | 51.64M | 602.5K | 20.46M | 8-K |
| 2025May 22, 2025 | 90.5% | 334M | 35.19M | 2.70M | 20.82M | 8-K |
| 2024May 23, 2024 | 90.9% | 351M | 34.98M | 596.9K | 23.10M | 8-K |
| 2023May 19, 2023 | 93.2% | 374M | 27.11M | 706.0K | 19.21M | 8-K |
| 2022May 20, 2022 | 93.4% | 375M | 26.40M | 632.1K | 19.01M | 8-K |
| 2021May 21, 2021 | 92.1% | 367M | 31.64M | 649.3K | 21.13M | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHEiShares U.S. Pharmaceuticals ETFWeight in the fund3.73%
- PPHVanEck Pharmaceutical ETFWeight in the fund2.10%
- MOATVanEck Morningstar Wide Moat ETFWeight in the fund1.82%
- VFLOVictoryShares Free Cash Flow ETFWeight in the fund1.26%
- FTCSFirst Trust Capital Strength ETFWeight in the fund1.18%
- IWPiShares Russell Mid-Cap Growth ETFWeight in the fund0.65%
- COWZPacer US Cash Cows 100 ETFWeight in the fund0.62%
- VOTVanguard Mid-Cap Growth Index FundWeight in the fund0.60%
- IYHiShares U.S. Healthcare ETFWeight in the fund0.54%
- XLVState Street(R) Health Care Select Sector SPDR(R) ETFWeight in the fund0.52%
60 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 1,807
- Q4 2025: Managers 1,688
- Q1 2026: Managers 1,624
- Q2 2026: Managers 1,428
Institutional investors by quarter
The fund managers holding ZTS, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 1,428 managers held 397M shares, worth $28.6B. During the quarter 169 opened a position, 365 closed one, 504 added and 594 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+11%
- Vanguard Capital ManagementIn the quarter-0.2%
- Vanguard Portfolio ManagementIn the quarter-0.4%
- State StreetIn the quarter+1.8%
- State Farm Mutual Automobile InsuranceIn the quarter
- Geode Capital ManagementIn the quarter+17%
- Wellington Management GroupIn the quarter-7.2%
- Morgan StanleyIn the quarter-37%
- Nordea Investment Management AbIn the quarter+12%
- Deutsche Bank Ag\In the quarter+5.8%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 39.43M | +11% | $2.8B |
| Vanguard Capital Management | 26.03M | -0.2% | $1.9B |
| Vanguard Portfolio Management | 23.86M | -0.4% | $1.7B |
| State Street | 19.67M | +1.8% | $1.4B |
| State Farm Mutual Automobile Insurance | 15.89M | $1.1B | |
| Geode Capital Management | 13.29M | +17% | $952M |
| Wellington Management Group | 9.42M | -7.2% | $677M |
| Morgan Stanley | 8.88M | -37% | $638M |
| Nordea Investment Management Ab | 6.59M | +12% | $472M |
| Deutsche Bank Ag\ | 5.85M | +5.8% | $421M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do Zoetis's filings show?
Who buys and sells is one part of Zoetis's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ZTS's insiders bought or sold?
From May 26, 2026 to Nov 3, 2026 Zoetis's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold ZTS?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $229M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.